echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Br J Cancer: Body Mass Index (BMI) and Absolute Lymphocyte Count (ALC): Predictors of disease-free survival for breast cancer patients

    Br J Cancer: Body Mass Index (BMI) and Absolute Lymphocyte Count (ALC): Predictors of disease-free survival for breast cancer patients

    • Last Update: 2021-05-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In recent decades, the global prevalence of breast cancer has been increasing year by year.
    As one of the most common malignant tumors in women, there were more than 2,000 deaths in South Korea in 2016.

    Breast cancer

    Because breast cancer is a heterogeneous disease with multiple biological characteristics, factors such as hormone receptors, HER2 (human epidermal growth factor receptor 2), disease stage, and Ki-67 marker index (LI) will all affect Affect the prognosis of patients.

    Breast cancer is a heterogeneous disease with multiple biological characteristics.
    Breast cancer is a heterogeneous disease with multiple biological characteristics.


    Obesity is another major health problem of global concern.


    In South Korea, more than 60% of women over 40 are overweight or obese.



    The study aims to assess the correlation between body mass index (BMI) and absolute lymphocyte count (ALC) in breast cancer patients and healthy women, and to determine the prognostic value of these factors in breast cancer.

    The study aims to assess the correlation between body mass index (BMI) and absolute lymphocyte count (ALC) in breast cancer patients and healthy women, and to determine the prognostic value of these factors in breast cancer.
    The study aims to assess the correlation between body mass index (BMI) and absolute lymphocyte count (ALC) in breast cancer patients and healthy women, and to determine the prognostic value of these factors in breast cancer.


    In this study, the researchers analyzed 1225 primary invasive breast cancer patients and 35,991 healthy female participants, and used a multivariate Cox risk ratio model to evaluate the relationship between the BMI index and disease-free survival (DFS) of the patients.


    A variety of factors including the complete blood count.



    Compare ALC box plots based on BMI

    Compare ALC box plots based on BMI

    The results showed that there was a positive correlation between BMI and ALC in breast cancer patients and healthy women.


    In a multivariate analysis, compared with underweight or normal individuals, overweight or obese participants had worse DFS, and patients with high ALC had better DFS than patients with low ALC.



    After risk stratification based on BMI/ALC data, the researchers found that high-risk patients with high BMI/low ALC had worse DFS compared to other patients.


    Kaplan-Meier Survival Curve Analysis

    Kaplan-Meier Survival Curve Analysis

    All in all, the results of the study showed that participants' BMI index and ALC were positively correlated, but the prognosis of breast cancer patients was opposite.


    Patients with high BMI/low ALC have worse DFS than other patients.


    Patients with high BMI/low ALC have worse DFS than other patients.



    org/10.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.